Omid Farokhzad: From Tehran to the Edge of Nanomedicine

At SEER, his work centered on expanding the boundaries of proteomic analysis using nanotechnology. Traditional proteomics often struggles with complexity, but the nanoscale tools developed by his team now allow researchers to examine proteins in blood and tissue samples with unprecedented speed and detail. Because proteins are the primary executors of cellular activity, this technology opens a window into the earliest changes that occur in the body during disease development.